Literature DB >> 17242058

Mouse model of oral infection with virulent type A Francisella tularensis.

R KuoLee1, X Zhao, J Austin, G Harris, J W Conlan, W Chen.   

Abstract

Francisella tularensis is a gram-negative facultative intracellular pathogen and the causative agent of tularemia. Little is known about the immunopathogenesis of oral infection with this pathogen. Here, for the first time, we examined the susceptibility of mice to intragastric inoculation with virulent type A F. tularensis and characterized the course of infection and the associated host responses. Both immunocompetent and immunodeficient mice were relatively susceptible to intragastric inoculation of type A F. tularensis with a 50% lethal dose (LD(50)) of 10(6) organisms, which was 100,000-fold higher than the LD(100) for intradermal or respiratory routes of infection. Mice deficient in gamma interferon or tumor necrosis factor receptors 1 and 2 were more susceptible than wild-type controls to oral infection with a high dose of the pathogen. After oral inoculation, F. tularensis appeared first in the mesenteric lymph nodes (MLN) and then rapidly spread to the livers and spleens, where the organism multiplied to high numbers and induced marked neutrophilic infiltration and severe tissue necrosis. Infected mice showed rapid increases in tissue cytokine mRNA expression, which peaked in the MLN at 2 days postinfection (dpi) and in the liver and spleen at 3 dpi. The levels of gamma interferon, interleukin-1beta (IL-1beta), IL-6, tumor necrosis factor alpha, macrophage inflammatory protein 1alpha, KC, interferon-inducible protein 10, and monocyte chemotactic protein 1 were elevated from day 2 postinoculation onward. Moreover, mice intradermally immunized with the live vaccine strain of F. tularensis showed little survival advantage over naive mice after oral challenge with type A F. tularensis. These results suggest that type A F. tularensis is an effective oral pathogen that can cause fatal systemic infection and could pose a public health concern, particularly to immunocompromised individuals, if ingested in contaminated water and food.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242058      PMCID: PMC1865681          DOI: 10.1128/IAI.01834-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes.

Authors:  A Vazquez-Torres; J Jones-Carson; A J Bäumler; S Falkow; R Valdivia; W Brown; M Le; R Berggren; W T Parks; F C Fang
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

2.  A waterborne tularemia outbreak.

Authors:  D Greco; G Allegrini; T Tizzi; E Ninu; A Lamanna; S Luzi
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

3.  Oral tularemia vaccine in man.

Authors:  R B Hornick; A T Dawkins; H T Eigelsbach; J J Tulis
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

4.  Oral vaccination against tularemia in the monkeys.

Authors:  J J Tulis; H T Eigelsbach; R B Hornick
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

5.  Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces.

Authors:  Nicole A Judge; Hugh S Mason; Alison D O'Brien
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice.

Authors:  W Chen; J A Harp; A G Harmsen; E A Havell
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Experimental Yersinia pestis infection in rodents after intragastric inoculation and ingestion of bacteria.

Authors:  T Butler; Y S Fu; L Furman; C Almeida; A Almeida
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Weight reduction of thymus and depletion of lymphocytes of T-dependent areas in peripheral lymphoid tissues of mice infected with Francisella tularensis.

Authors:  M Ito; K Nishiyama; S Hyodo; S Shigeta; T Ito
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

9.  Live vaccine strain of Francisella tularensis: infection and immunity in mice.

Authors:  A H Fortier; M V Slayter; R Ziemba; M S Meltzer; C A Nacy
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine.

Authors:  Penelope D Barnes; Molly A Bergman; Joan Mecsas; Ralph R Isberg
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

View more
  14 in total

Review 1.  Ecology of Francisella tularensis.

Authors:  Sam R Telford; Heidi K Goethert
Journal:  Annu Rev Entomol       Date:  2019-10-10       Impact factor: 19.686

2.  Infection of mice with Francisella as an immunological model.

Authors:  J Wayne Conlan; Wangxue Chen; Catharine M Bosio; Siobhán C Cowley; Karen L Elkins
Journal:  Curr Protoc Immunol       Date:  2011-04

3.  The Natural History of Pneumonic Tularemia in Female Fischer 344 Rats after Inhalational Exposure to Aerosolized Francisella tularensis Subspecies tularensis Strain SCHU S4.

Authors:  Julie A Hutt; Julie A Lovchik; Alexander Dekonenko; Andrew C Hahn; Terry H Wu
Journal:  Am J Pathol       Date:  2016-12-08       Impact factor: 4.307

4.  Knockout of the Bcmo1 gene results in an inflammatory response in female lung, which is suppressed by dietary beta-carotene.

Authors:  Yvonne G J van Helden; Sandra G Heil; Frederik J van Schooten; Evelien Kramer; Susanne Hessel; Jaume Amengual; Joan Ribot; Katja Teerds; Adrian Wyss; Georg Lietz; M Luisa Bonet; Johannes von Lintig; Roger W L Godschalk; Jaap Keijer
Journal:  Cell Mol Life Sci       Date:  2010-04-06       Impact factor: 9.261

5.  Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.

Authors:  Damiana Chiavolini; Joseph Alroy; Carol A King; Peter Jorth; Susan Weir; Guillermo Madico; John R Murphy; Lee M Wetzler
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

6.  Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis.

Authors:  Constantine Bitsaktsis; Deepak B Rawool; Ying Li; Nitin V Kurkure; Bibiana Iglesias; Edmund J Gosselin
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Use of temperature for standardizing the progression of Francisella tularensis in mice.

Authors:  Claudia R Molins; Mark J Delorey; John W Young; Brook M Yockey; John T Belisle; Martin E Schriefer; Jeannine M Petersen
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

8.  Host-pathogen o-methyltransferase similarity and its specific presence in highly virulent strains of Francisella tularensis suggests molecular mimicry.

Authors:  Mia D Champion
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

9.  Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthma.

Authors:  Hongyu Qiu; Rhonda Kuolee; Greg Harris; Hongyan Zhou; Harvey Miller; Girishchandra B Patel; Wangxue Chen
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

10.  Lymphotoxin-alpha plays only a minor role in host resistance to respiratory infection with virulent type A Francisella tularensis in mice.

Authors:  Deng Zhang; Rhonda Kuolee; Greg Harris; Qinxian Zhang; J Wayne Conlan; Wangxue Chen
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.